Stockholders' Equity (Details) - USD ($)			3 Months Ended		12 Months Ended
	May 08, 2025	Jan. 02, 2025	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025	Dec. 30, 2024
Stockholders’ Equity [Line Items]
Company issued with acquisition		4,000,000
Unrecognized compensation expense (in Dollars)					$ 560,674
Weighted average period					3 years 6 months
Intrinsic value of stock options (in Dollars)			$ 13,140		$ 16,920
Purchase of common stock			40,000
Exercise price (in Dollars per share)				$ 1.79
Common stock purchase shares			276,000
Fair value of options granted (in Dollars)			$ 445,439
Stock-based compensation expense (in Dollars)			$ 23,556	$ 167,629
Preferred stock authorized shares						9,000,000
Stock repurchase plan (in Dollars)	$ 400,000
Common stock repurchase plan			50,000
Average price per share (in Dollars per share)			$ 1.67
Aggregate amount (in Dollars)			$ 83,491
Common stock shares authorized			50,000,000		50,000,000
Common stock, treasury shares			843,221		793,221
2011 Long-Term Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Number of stock options were exercised			2,487
2025 Long-Term Incentive Plan [Member]
Stockholders’ Equity [Line Items]
Shares available for future issuance			1,001,037
Share-Based Payment Arrangement, Option [Member]
Stockholders’ Equity [Line Items]
Exercise price (in Dollars per share)			$ 1.62	$ 1.41
Fair value of options granted (in Dollars)				$ 545,550
Share-Based Payment Arrangement, Option [Member] | Board of Directors Chairman [Member]
Stockholders’ Equity [Line Items]
Exercise price (in Dollars per share)			$ 1.62
Common Stock [Member]
Stockholders’ Equity [Line Items]
Company issued with acquisition	1,200,000
Number of stock options were exercised			682,550
Minimum [Member]
Stockholders’ Equity [Line Items]
Common stock shares authorized	25,000,000
Maximum [Member]
Stockholders’ Equity [Line Items]
Common stock shares authorized	50,000,000